Assertio Therapeutics Inc (ASRT) — Defensive Interval Ratio
Assertio Therapeutics Inc (ASRT) has a Defensive Interval Ratio of 396 days as of March 2026. Defensive assets of $99.38 Million (cash $-, short-term investments $37.86 Million, receivables $61.53 Million) cover 396 days of daily cash needs of $250.88K/day. See working capital position of Assertio Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Assertio Therapeutics Inc Defensive Interval Ratio (1996–2025)
This chart shows how Assertio Therapeutics Inc's Defensive Interval Ratio has evolved across 30 annual periods from 1996 to 2025. As of March 2026, the ratio stands at 396 days, meaning defensive assets of $99.38 Million can fund 396 days of operations without new revenue. See ASRT equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Assertio Therapeutics Inc (1996–2025)
The table below presents the year-by-year Defensive Interval Ratio for Assertio Therapeutics Inc from 1996 to 2025, covering 30 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Assertio Therapeutics Inc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 496 days | $173.29 Million | $349.35K/day | $- | $53.18 Million | ▲ +166 days |
| 2024 | 330 days | $103.59 Million | $314.21K/day | $- | $49.47 Million | ▲ +143 days |
| 2023 | 186 days | $47.66 Million | $256.01K/day | $- | $0.00 | ▲ +12 days |
| 2022 | 174 days | $45.36 Million | $261.14K/day | $- | $- | ▲ +55 days |
| 2021 | 118 days | $43.75 Million | $369.92K/day | $- | $- | ▼ -8 days |
| 2020 | 126 days | $45.93 Million | $363.52K/day | $- | $1.58 Million | ▲ +42 days |
| 2019 | 85 days | $42.74 Million | $505.62K/day | $- | $- | ▼ -24 days |
| 2018 | 109 days | $37.21 Million | $342.20K/day | $- | $0.00 | ▼ -11 days |
| 2017 | 120 days | $73.69 Million | $614.80K/day | $- | $1.21 Million | ▼ -147 days |
| 2016 | 267 days | $162.30 Million | $607.59K/day | $- | $59.71 Million | ▼ -79 days |
| 2015 | 346 days | $186.73 Million | $539.16K/day | $- | $108.68 Million | ▼ -366 days |
| 2014 | 713 days | $102.88 Million | $144.35K/day | $- | $70.77 Million | ▲ +561 days |
| 2013 | 152 days | $49.54 Million | $326.65K/day | $- | $27.26 Million | ▼ -214 days |
| 2012 | 365 days | $51.43 Million | $140.73K/day | $- | $37.74 Million | ▼ -319 days |
| 2011 | 684 days | $74.66 Million | $109.15K/day | $- | $62.11 Million | ▲ +85 days |
| 2010 | 599 days | $54.17 Million | $90.37K/day | $- | $47.83 Million | ▲ +57 days |
| 2009 | 542 days | $47.85 Million | $88.22K/day | $- | $42.92 Million | ▼ -495 days |
| 2008 | 1037 days | $63.61 Million | $61.31K/day | $- | $59.93 Million | ▼ -50 days |
| 2007 | 1088 days | $42.71 Million | $39.27K/day | $- | $39.09 Million | ▲ +662 days |
| 2006 | 426 days | $26.07 Million | $61.20K/day | $- | $16.98 Million | ▼ -1992 days |
| 2005 | 2418 days | $53.46 Million | $22.11K/day | $- | $51.51 Million | ▲ +616 days |
| 2004 | 1802 days | $17.15 Million | $9.52K/day | $- | $17.15 Million | ▼ -668 days |
| 2003 | 2470 days | $24.49 Million | $9.91K/day | $- | $24.21 Million | ▲ +2088 days |
| 2002 | 383 days | $8.99 Million | $23.49K/day | $- | $8.68 Million | ▲ +301 days |
| 2001 | 82 days | $1.04 Million | $12.76K/day | $- | $- | ▼ -391 days |
| 2000 | 472 days | $3.07 Million | $6.51K/day | $- | $2.62 Million | ▼ -114 days |
| 1999 | 586 days | $20.55 Million | $35.08K/day | $- | $3.53 Million | ▲ +403 days |
| 1998 | 183 days | $300.00K | $1.64K/day | $- | $- | ▲ +91 days |
| 1997 | 91 days | $100.00K | $1.10K/day | $- | $- | ▲ +39 days |
| 1996 | 52 days | $100.00K | $1.92K/day | $- | $- | — |